Literature DB >> 17413628

Efficacy of skin cooling and EMLA cream application for pain relief of periocular botulinum toxin injection.

Orhan Elibol1, Berna Ozkan, Pelin Kaynak Hekimhan, Yusuf Cağlar.   

Abstract

PURPOSE: To investigate the efficacy of EMLA cream and local dry cold application for pain relief before periocular botulinum toxin injection, and to compare these two methods.
METHODS: In this prospective study, 40 patients underwent bilateral periocular botulinum injections for blepharospasm treatment or wrinkle reduction. Patients were divided into three treatment groups. In the first group (n = 12), cold was applied to the periocular area on one side before injection; the other side served as the control. In the second group (n = 12), topical anesthetic cream (EMLA) was applied to one side and the other side served as the control. In the third group (n = 16), cold was applied to one side and EMLA was applied to the other side. A visual analog scale was used for pain intensity, and patients in the third group were asked which treatment they preferred.
RESULTS: In the first group, the average pain score on the side where cold was applied was 3.00 +/- 1.70, whereas it was 5.83 +/- 1.40 on the control side (p < 0.001). In the second group, the average pain score on the side receiving EMLA was 3.25 +/- 1.86, and on the control side was 5.83 +/- 1.89 (p < 0.001). In the third group, the average pain score was 3.18 +/- 1.68 for the EMLA side and 3.12 +/- 1.31 for the cooled side (p > 0.05); nine of the 16 patients (56.2%) preferred EMLA.
CONCLUSIONS: Skin cooling and EMLA applications significantly decrease the pain associated with periocular botulinum toxin injections. Clinically or statistically significant difference in pain scores between the two methods was not noted. Patients had a slight preference for EMLA cream over skin cooling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413628     DOI: 10.1097/IOP.0b013e318030459c

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  7 in total

1.  The use of a contact cooling device to reduce pain and ecchymosis associated with dermal filler injections.

Authors:  Mark S Nestor; Glynis R Ablon; Mark A Stillman
Journal:  J Clin Aesthet Dermatol       Date:  2010-03

Review 2.  Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.

Authors:  Maria Fiorella Contarino; Joost Van Den Dool; Yacov Balash; Kailash Bhatia; Nir Giladi; Johannes H Koelman; Annemette Lokkegaard; Maria J Marti; Miranda Postma; Maja Relja; Matej Skorvanek; Johannes D Speelman; Evelien Zoons; Joaquim J Ferreira; Marie Vidailhet; Alberto Albanese; Marina A J Tijssen
Journal:  Front Neurol       Date:  2017-02-24       Impact factor: 4.003

3.  Strategies to decrease injection site pain in botulinum toxin therapy.

Authors:  Lejla Paracka; Katja Kollewe; Florian Wegner; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2017-07-24       Impact factor: 3.575

4.  Noncosmetic periocular therapeutic applications of botulinum toxin.

Authors:  Pelin Kaynak-Hekimhan
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

Review 5.  Current and Emerging Medical Therapies for Primary Hyperhidrosis.

Authors:  Daniel A Grabell; Adelaide A Hebert
Journal:  Dermatol Ther (Heidelb)       Date:  2016-10-27

6.  Comparison of the Effect of EMLA™ Cream and the Valsalva Maneuver on Pain Severity during Vascular Needle Insertion in Hemodialysis Patients: A Controlled, Randomized, Clinical Trial.

Authors:  Hassan Babamohamadi; Zahra Ameri; Ilia Asadi; Mohammad Reza Asgari
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-31       Impact factor: 2.650

7.  Vapocoolant Anesthesia for Cosmetic Facial Rejuvenation Injections: A Randomized, Prospective, Split-Face Trial.

Authors:  Matthew R Zeiderman; Shahrooz Sean Kelishadi; John Paul Tutela; Arun Rao; Saeed Chowdhry; Ronald M Brooks; Bradon J Wilhelmi
Journal:  Eplasty       Date:  2018-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.